AdAlta (ASX:1AD) Beginning Cash Position : A$4.79 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is AdAlta Beginning Cash Position?

AdAlta's Beginning Cash Position for the quarter that ended in Dec. 2023 was A$4.79 Mil.

AdAlta's quarterly Beginning Cash Position declined from Dec. 2022 (A$8.66 Mil) to Jun. 2023 (A$8.60 Mil) and declined from Jun. 2023 (A$8.60 Mil) to Dec. 2023 (A$4.79 Mil).

AdAlta's annual Beginning Cash Position increased from Jun. 2021 (A$3.37 Mil) to Jun. 2022 (A$5.79 Mil) and increased from Jun. 2022 (A$5.79 Mil) to Jun. 2023 (A$8.66 Mil).

AdAlta Beginning Cash Position Historical Data

The historical data trend for AdAlta's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AdAlta Beginning Cash Position Chart

AdAlta Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Beginning Cash Position

Get a 7-Day Free Trial

2.31

5.56

3.37

5.79

8.66

AdAlta Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial										5.79	9.08	8.66	8.60	4.79

AdAlta Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

AdAlta Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of AdAlta's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

AdAlta (ASX:1AD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AdAlta Ltd (ASX:1AD) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Park Drive, Unit 15, Bundoora, VIC, AUS, 3083

Website

https://www.adalta.com.au

AdAlta Ltd is engaged in drug discovery and development company developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis, and CAR-T cancer therapeutics.

AdAlta (ASX:1AD) Headlines

No Headlines